Every day more than 300 people in the U.S. die from opioid overdose.

By Staff Reports

Santa Clara Valley Healthcare and its three hospitals, Santa Clara Valley Medical Center, O’Connor Hospital and St. Louise Regional Hospital, have been recognized by Cal Hospital Compare for its opioid abuse disorder abatement efforts and by the American Heart Association for achievements in stroke care.

CHC, a performance reporting initiative managed by a multi-stakeholder board of directors, recognized the hospitals in their 2023 Opioid Honor Roll Program, awarding an “Excellent Progress” rating for increased access to addiction treatment. Recipient hospitals identified and used best practices to treat patients with Opioid Use Disorder, initiated and analyzed overdose prevention methods while applying cross-cutting opioid management.

Every day more than 300 people in the U.S. die from opioid overdose.

“We’re honored to be recognized for our in-place protocols to help alleviate the burgeoning opioid use disorder pandemic,” said Paul E. Lorenz, chief executive officer for Santa Clara Valley Healthcare.

SCVH also received the highest accolade from the American Heart Association, bestowing the hospitals with the Stroke Gold Plus Award for achieving specific targets for stroke treatment and Type 2 diabetes management and prevention. The designation highlights SCVH’s efforts to ensure quality care is provided to patients and aligned with the latest research-based guidelines based on specific evidence for stroke treatment.

SCVH earned this recognition by reaching an aggressive goal of treating patients to core standard levels of care as outlined by the American Heart Association/American Stroke Association for two consecutive calendar years or more.